Aldioxa is a gastrointestinal agent classified as an aluminum dihydroxy allantoinate, utilized primarily as a mucosal protective agent to treat gastric ulcers, duodenal ulcers, and gastritis, as well as… Read more
Aldioxa is a gastrointestinal agent classified as an aluminum dihydroxy allantoinate, utilized primarily as a mucosal protective agent to treat gastric ulcers, duodenal ulcers, and gastritis, as well as to improve delayed gastric emptying. To support the rigorous demands of pharmaceutical research and development, this category provides high-quality reference standards of the active ingredient, alongside its identified impurities, metabolites, and stable isotope labelled compounds. These materials are essential for precise impurity profiling, method validation, and routine quality control protocols in analytical laboratories. By providing verified standards for both pharmacopeial and non-pharmacopeial impurities, these products enable laboratories to ensure the safety, efficacy, and purity of drug formulations throughout the manufacturing lifecycle. Whether conducting stability studies or developing new analytical methods, access to these specialized compounds is critical for maintaining regulatory compliance and ensuring accurate results in the characterization of this prokinetic therapeutic agent.